Biological and biochemical effects of chartreusin on mammalian cells.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000378:metabolism / Q000494:pharmacology*; D001578:Benzopyrans; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000378:metabolism; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006027:Glycosides / Q000378:metabolism / Q000494:pharmacology; D007942:Leukemia, Experimental / Q000188:drug therapy* / Q000378:metabolism; D009363:Neoplasm Proteins / Q000096:biosynthesis; D019384:Nucleic Acid Synthesis Inhibitors; D011067:Poly dA-dT / Q000378:metabolism; D012319:RNA Polymerase II / Q000037:antagonists & inhibitors; D012334:RNA, Neoplasm / Q000096:biosynthesis
D000903:Antibiotics, Antineoplastic; D001578:Benzopyrans; D004273:DNA, Neoplasm; D006027:Glycosides; D009363:Neoplasm Proteins; D019384:Nucleic Acid Synthesis Inhibitors; D012334:RNA, Neoplasm; D011067:Poly dA-dT; D004247:DNA; D012319:RNA Polymerase II; C002185:chartreusin